[DPHARMA] YoY Quarter Result on 30-Jun-2024 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- 9.24%
YoY- 33.08%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 218,324 167,516 181,742 155,439 143,331 145,466 123,991 9.87%
PBT 21,960 16,515 21,473 20,197 19,391 18,316 12,915 9.24%
Tax -5,271 -3,974 -5,162 -4,807 -4,662 -4,400 -2,576 12.66%
NP 16,689 12,541 16,311 15,390 14,729 13,916 10,339 8.29%
-
NP to SH 16,689 12,541 16,311 15,390 14,729 13,916 10,339 8.29%
-
Tax Rate 24.00% 24.06% 24.04% 23.80% 24.04% 24.02% 19.95% -
Total Cost 201,635 154,975 165,431 140,049 128,602 131,550 113,652 10.01%
-
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div 9,619 4,788 4,734 3,530 3,421 6,618 4,199 14.80%
Div Payout % 57.64% 38.19% 29.02% 22.94% 23.23% 47.56% 40.62% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
NOSH 961,942 961,942 952,239 706,330 684,383 661,881 650,902 6.72%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 7.64% 7.49% 8.97% 9.90% 10.28% 9.57% 8.34% -
ROE 2.41% 1.87% 2.57% 2.51% 2.53% 2.77% 4.92% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 22.70 17.49 19.19 22.01 20.94 21.98 44.29 -10.53%
EPS 1.73 1.31 1.72 2.18 2.15 2.07 1.59 1.41%
DPS 1.00 0.50 0.50 0.50 0.50 1.00 1.50 -6.52%
NAPS 0.72 0.70 0.67 0.87 0.85 0.76 0.75 -0.67%
Adjusted Per Share Value based on latest NOSH - 961,942
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 22.70 17.41 18.89 16.16 14.90 15.12 12.89 9.88%
EPS 1.73 1.30 1.70 1.60 1.53 1.45 1.07 8.32%
DPS 1.00 0.50 0.49 0.37 0.36 0.69 0.44 14.64%
NAPS 0.72 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 21.98%
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 1.26 1.30 1.20 3.03 1.62 1.37 1.30 -
P/RPS 5.55 7.43 6.25 13.77 7.74 6.23 2.94 11.16%
P/EPS 72.63 99.28 69.66 139.03 75.27 65.16 35.20 12.81%
EY 1.38 1.01 1.44 0.72 1.33 1.53 2.84 -11.32%
DY 0.79 0.38 0.42 0.17 0.31 0.73 1.15 -6.06%
P/NAPS 1.75 1.86 1.79 3.48 1.91 1.80 1.73 0.19%
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 15/08/24 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 -
Price 1.17 1.19 1.34 2.49 3.15 1.41 1.08 -
P/RPS 5.16 6.80 6.98 11.31 15.04 6.42 2.44 13.28%
P/EPS 67.44 90.88 77.78 114.25 146.36 67.06 29.25 14.92%
EY 1.48 1.10 1.29 0.88 0.68 1.49 3.42 -13.01%
DY 0.85 0.42 0.37 0.20 0.16 0.71 1.39 -7.86%
P/NAPS 1.62 1.70 2.00 2.86 3.71 1.86 1.44 1.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment